Background Image
Table of Contents Table of Contents
Previous Page  49 / 78 Next Page
Information
Show Menu
Previous Page 49 / 78 Next Page
Page Background

CARDIOVASCULAR JOURNAL OF AFRICA • Volume 26, No 4, July/August 2015

AFRICA

195

References

1.

Lim SS, Vos T, Flaxman AD, Danaei G, Shibuya K,

et al.

A comparative

risk assessment of disease and injury attributable to 67 risk factors and

risk factor clusters in 21 regions, 1990–2010: a systematic review analysis

for the Global Burden of Disease Study.

Lancet

2013;

380

: 2224–2260.

2.

Campbell NR, Nieylski M, Lackland D. High blood pressure: why

prevention and control are urgent and important. A fact sheet from

the World Hypertension League and the International Society of

Hypertension.

J Clin Hypertens

2014;

16

: 551–553.

3.

Seedat YK. Race, environment and blood pressure: The South African

experience.

J Hypertens

1983;

1

: 7–12.

4.

Steyn K, Gaziano TA, Bradshaw D, Laubscher R,

et al

. South African

Demographic and Health Coordinating Team. Hypertension in South

African adults: results from the Demographic and Health Survey, 1998.

J Hypertens

2001;

19

: 739–747.

5.

Oxfam report. Big pharmaceutical companies need to change the way

they work to reach 83% of the worlds’ consumers who don’t have proper

access to medicine. 28-11-2007. http://www. Oxfam org/en/policy/brief-

ing papers/bp109_for life_0711.

6.

Steinbrook R. Closing the affordability for drugs in low-income coun-

tries.

N Eng J Med

2007;

357

: 1996–1999.

7.

Seedat YK. Fixed drug combination in hypertension and hyperlidaemia

in the developing world.

Cardiovasc J Afr

2008;

19

: 124–126.

8.

Seedat YK. Impact of poverty on hypertension and cardiovascular

disease in sub-Saharan Africa.

Cardiovasc J Afr

2007;

18

: 316–320.

9.

United Nation Population Fact. Health workers, international migration

and development, August 2010. No. 2010/2.E/Rev: 1–4.

10. Douglas JG, Bakris GL, Epstein M, Ferdinand KC,

et al

. Management

of high blood pressure in African Americans: consensus statement

of the Hypertension Americans Working Group of the International

Society on Hypertension in Blacks.

Arch Intern Med

2003;

163

: 525–541.

11. LemogoumD, Seedat YK, Mabadeje AFB, Mendis S. Recommendations

for prevention, diagnosis and management of hypertension, and cardio-

vascular risk factors in sub-Saharan Africa.

J Hypertens

2003;

21

:

1993–2000.

12. MacMahon S, Alderman MH. Lindholm LH, Liu L,

et al.

Blood

pressure-related disease is a global health priority.

Lancet

2008;

371

:

1480–1482.

13. Seedat YK. Control of hypertension in South Africa: Time for action.

S

Afr Med J

2012;

102

: 25–26.

Cephas Musabayane, 1948–2015

It is with sadness that we report the death of Prof Cephas

Musabayane, professor of physiology at the University of

KwaZulu-Natal, and leader of a team of researchers who

discovered a new method of administering insulin into the

bloodstream via a skin patch. The discovery could eventually

pave the way for diabetic patients to control their insulin levels in

a pain-free manner with reduced negative side effects.

Musabayane was born in Zimbabwe and when his academic

potential was recognised, he was sent to England to finish his

schooling. He obtained his BSc from Hertfordshire University

in the UK, and then returned to the University of Zimbabwe

where he obtained his MSc and PhD. He joined the University

of KwaZulu-Natal as professor of human physiology in 2003,

and served as head of the School of Medical Sciences for four

years.

Musabayane was an academic who was passionate about

teaching and research. He inspired his students and motivated

them to achieve success. His areas of research included diabetes,

malaria and renal physiology, and he obtained national and

international recognition for his work. He was a life fellow of the

Physiology Society of Southern Africa and a member of the US

and UK physiological societies.

In Africa, plants have always served as a dependable and

ever-ready source of medicines for the treatment of a plethora of

chronic and acute diseases. Traditional remedies have been used

for ailments such as hypertension, diabetes mellitus, arthritis and

erectile dysfunction, among others. In a search for plants with

the potential for use as effective and safe ethnomedical remedies

in the management of a range of human diseases, Musabayane

and colleagues subjected many African medicinal plants to

phytochemical and pharmacological investigation. They showed

that some African medicinal plants possess hypoglycaemic, anti-

inflammatory, analgesic and other pharmacological properties.

Musabayane published several articles in the

Cardiovascular

Journal of Africa

on the effects of medicinal plants on glucose

concentrations, renal function and blood pressure in normal

and diabetic laboratory animals. His aim was to develop some

of the existing African traditional remedies into scientifically

acceptable natural remedies that are affordable, safe and effective.

He believed that the goals of medicine, whether allopathic,

traditional or complementary, are the same, namely to benefit

patients therapeutically and improve their quality of life. He

hoped to help develop affordable, safe and effective natural

medicines for various human diseases.

In Memoriam